Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial

Objective: To assess whether non-clinical staff can effectively manage people at high risk of cardiovascular disease using digital health technologies. Design: Pragmatic, multicentre, randomised controlled trial. Setting: 42 general practices in three areas of England. Participants: Between 3 Dec...

Full description

Bibliographic Details
Main Authors: Salisbury, Chris, O'Cathain, Alicia, Thomas, Clare, Edwards, Louisa, Gaunt, Daisy, Dixon, Padraig, Hollingshurst, Sandra, Nicholl, Jon, Large, Shirley, Yardley, Lucy, Fahey, Tom, Foster, Alexis, Garner, Katy, Horspool, Kimberley, Man, Mei-See, Rogers, Anne Elizabeth, Pope, Catherine, Montgomery, Alan A.
Format: Article
Published: BMJ Publishing Group Ltd 2016
Online Access:https://eprints.nottingham.ac.uk/44809/
_version_ 1848797001947283456
author Salisbury, Chris
O'Cathain, Alicia
Thomas, Clare
Edwards, Louisa
Gaunt, Daisy
Dixon, Padraig
Hollingshurst, Sandra
Nicholl, Jon
Large, Shirley
Yardley, Lucy
Fahey, Tom
Foster, Alexis
Garner, Katy
Horspool, Kimberley
Man, Mei-See
Rogers, Anne Elizabeth
Pope, Catherine
Montgomery, Alan A.
author_facet Salisbury, Chris
O'Cathain, Alicia
Thomas, Clare
Edwards, Louisa
Gaunt, Daisy
Dixon, Padraig
Hollingshurst, Sandra
Nicholl, Jon
Large, Shirley
Yardley, Lucy
Fahey, Tom
Foster, Alexis
Garner, Katy
Horspool, Kimberley
Man, Mei-See
Rogers, Anne Elizabeth
Pope, Catherine
Montgomery, Alan A.
author_sort Salisbury, Chris
building Nottingham Research Data Repository
collection Online Access
description Objective: To assess whether non-clinical staff can effectively manage people at high risk of cardiovascular disease using digital health technologies. Design: Pragmatic, multicentre, randomised controlled trial. Setting: 42 general practices in three areas of England. Participants: Between 3 December 2012 and 23 July 2013 we recruited 641 adults aged 40 to 74 years with a 10 year cardiovascular disease risk of 20% or more, no previous cardiovascular event, at least one modifiable risk factor (systolic blood pressure ≥140 mm Hg, body mass index ≥30, current smoker), and access to a telephone, the internet, and email. Participants were individually allocated to intervention (n=325) or control (n=316) groups using automated randomisation stratified by site, minimised by practice and baseline risk score. Interventions: Intervention was the Healthlines service (alongside usual care), comprising regular telephone calls from trained lay health advisors following scripts generated by interactive software. Advisors facilitated self-management by supporting participants to use online resources to reduce risk factors, and sought to optimise drug use, improve treatment adherence, and encourage healthier lifestyles. The control group comprised usual care alone. Main outcome measures: The primary outcome was the proportion of participants responding to treatment, defined as maintaining or reducing their cardiovascular risk after 12 months. Outcomes were collected six and 12 months after randomisation and analysed masked. Participants were not masked. Results: 50% (148/295) of participants in the intervention group responded to treatment compared with 43% (124/291) in the control group (adjusted odds ratio 1.3, 95% confidence interval 1.0 to 1.9; number needed to treat=13); a difference possibly due to chance (P=0.08). The intervention was associated with reductions in blood pressure (difference in mean systolic −2.7 mm Hg (95% confidence interval −4.7 to −0.6 mm Hg), mean diastolic −2.8 (−4.0 to −1.6 mm Hg); weight −1.0 kg (−1.8 to −0.3 kg), and body mass index −0.4 (−0.6 to −0.1) but not cholesterol −0.1 (−0.2 to 0.0), smoking status (adjusted odds ratio 0.4, 0.2 to 1.0), or overall cardiovascular risk as a continuous measure (−0.4, −1.2 to 0.3)). The intervention was associated with improvements in diet, physical activity, drug adherence, and satisfaction with access to care, treatment received, and care coordination. One serious related adverse event occurred, when a participant was admitted to hospital with low blood pressure. Conclusions: This evidence based telehealth approach was associated with small clinical benefits for a minority of people with high cardiovascular risk, and there was no overall improvement in average risk. The Healthlines service was, however, associated with improvements in some risk behaviours, and in perceptions of support and access to care.
first_indexed 2025-11-14T19:56:56Z
format Article
id nottingham-44809
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:56:56Z
publishDate 2016
publisher BMJ Publishing Group Ltd
recordtype eprints
repository_type Digital Repository
spelling nottingham-448092020-05-04T17:48:56Z https://eprints.nottingham.ac.uk/44809/ Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial Salisbury, Chris O'Cathain, Alicia Thomas, Clare Edwards, Louisa Gaunt, Daisy Dixon, Padraig Hollingshurst, Sandra Nicholl, Jon Large, Shirley Yardley, Lucy Fahey, Tom Foster, Alexis Garner, Katy Horspool, Kimberley Man, Mei-See Rogers, Anne Elizabeth Pope, Catherine Montgomery, Alan A. Objective: To assess whether non-clinical staff can effectively manage people at high risk of cardiovascular disease using digital health technologies. Design: Pragmatic, multicentre, randomised controlled trial. Setting: 42 general practices in three areas of England. Participants: Between 3 December 2012 and 23 July 2013 we recruited 641 adults aged 40 to 74 years with a 10 year cardiovascular disease risk of 20% or more, no previous cardiovascular event, at least one modifiable risk factor (systolic blood pressure ≥140 mm Hg, body mass index ≥30, current smoker), and access to a telephone, the internet, and email. Participants were individually allocated to intervention (n=325) or control (n=316) groups using automated randomisation stratified by site, minimised by practice and baseline risk score. Interventions: Intervention was the Healthlines service (alongside usual care), comprising regular telephone calls from trained lay health advisors following scripts generated by interactive software. Advisors facilitated self-management by supporting participants to use online resources to reduce risk factors, and sought to optimise drug use, improve treatment adherence, and encourage healthier lifestyles. The control group comprised usual care alone. Main outcome measures: The primary outcome was the proportion of participants responding to treatment, defined as maintaining or reducing their cardiovascular risk after 12 months. Outcomes were collected six and 12 months after randomisation and analysed masked. Participants were not masked. Results: 50% (148/295) of participants in the intervention group responded to treatment compared with 43% (124/291) in the control group (adjusted odds ratio 1.3, 95% confidence interval 1.0 to 1.9; number needed to treat=13); a difference possibly due to chance (P=0.08). The intervention was associated with reductions in blood pressure (difference in mean systolic −2.7 mm Hg (95% confidence interval −4.7 to −0.6 mm Hg), mean diastolic −2.8 (−4.0 to −1.6 mm Hg); weight −1.0 kg (−1.8 to −0.3 kg), and body mass index −0.4 (−0.6 to −0.1) but not cholesterol −0.1 (−0.2 to 0.0), smoking status (adjusted odds ratio 0.4, 0.2 to 1.0), or overall cardiovascular risk as a continuous measure (−0.4, −1.2 to 0.3)). The intervention was associated with improvements in diet, physical activity, drug adherence, and satisfaction with access to care, treatment received, and care coordination. One serious related adverse event occurred, when a participant was admitted to hospital with low blood pressure. Conclusions: This evidence based telehealth approach was associated with small clinical benefits for a minority of people with high cardiovascular risk, and there was no overall improvement in average risk. The Healthlines service was, however, associated with improvements in some risk behaviours, and in perceptions of support and access to care. BMJ Publishing Group Ltd 2016-06-01 Article PeerReviewed Salisbury, Chris, O'Cathain, Alicia, Thomas, Clare, Edwards, Louisa, Gaunt, Daisy, Dixon, Padraig, Hollingshurst, Sandra, Nicholl, Jon, Large, Shirley, Yardley, Lucy, Fahey, Tom, Foster, Alexis, Garner, Katy, Horspool, Kimberley, Man, Mei-See, Rogers, Anne Elizabeth, Pope, Catherine and Montgomery, Alan A. (2016) Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ Open, 353 . i2647. ISSN 2044-6055 http://www.bmj.com/content/353/bmj.i2647 doi:10.1136/bmj.i2647 doi:10.1136/bmj.i2647
spellingShingle Salisbury, Chris
O'Cathain, Alicia
Thomas, Clare
Edwards, Louisa
Gaunt, Daisy
Dixon, Padraig
Hollingshurst, Sandra
Nicholl, Jon
Large, Shirley
Yardley, Lucy
Fahey, Tom
Foster, Alexis
Garner, Katy
Horspool, Kimberley
Man, Mei-See
Rogers, Anne Elizabeth
Pope, Catherine
Montgomery, Alan A.
Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title_full Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title_fullStr Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title_full_unstemmed Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title_short Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
title_sort telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial
url https://eprints.nottingham.ac.uk/44809/
https://eprints.nottingham.ac.uk/44809/
https://eprints.nottingham.ac.uk/44809/